[ORGANIZATION]
Eydenzelt
Featured in 1 tracked story · first seen
Situations
Celltrion biosimilar market expansion
4 clusters · 6 sources · last updated
Latest: Celltrion's Remsima reaches number one in Japan's infliximab market
Celltrion continues to expand its global biosimilar market share, particularly in autoimmune and oncology treatments. In the United States, the ustekinumab biosimilar Stekyma reached a 16.2% market share in July, marking